Dr William D Horton Ii, MD | |
7557a Dannaher Drive, Suite 210, Powell, TN 37849-3558 | |
(865) 521-8050 | |
(865) 544-8615 |
Full Name | Dr William D Horton Ii |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Experience | 41 Years |
Location | 7557a Dannaher Drive, Powell, Tennessee |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1811071525 | NPI | - | NPPES |
3710126 | Medicaid | TN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 18952 (Tennessee) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Of Tn Medical Center | Knoxville, TN | Hospital |
Leconte Medical Center | Sevierville, TN | Hospital |
Physicians Regional Medical Center | Powell, TN | Hospital |
Fort Sanders Regional Medical Center | Knoxville, TN | Hospital |
Parkwest Medical Center | Knoxville, TN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Greater Knoxville Ear Nose And Throat Associates Pc | 0244126126 | 21 |
News Archive
Imaging Dynamics Company Ltd. a global leader in the high growth digital radiography (DR) equipment market, today reported financial results for the first quarter ended March 31, 2010.
CLEAR, the powerful public and proprietary records service and investigative suite from Thomson Reuters, is well-regarded among law enforcement and government investigative professionals for helping nab criminals and recover missing children. Today, the business is introducing a new version of the service to aid in the recovery of the $60 billion that the National Health Care Anti-Fraud Association estimates is lost each year to fraud.
The U.S. Food and Drug Administration announced today that Baxter Healthcare Corporation has temporarily stopped manufacturing multiple-dose vials of the injectable blood-thinning drug heparin due to reports of serious allergic reactions and hypotension (low blood pressure) in patients who receive high "bolus" doses of the drug.
Data presented today at The International Liver Congress 2015 demonstrates that remogliflozin etabonate, an investigational drug in type 2 diabetes, is a potential treatment option for the management of patients with non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD).
Sorrento Therapeutics, Inc. announced today that it has completed its acquisition of Concortis Biosystems, Corp., providing Sorrento with a comprehensive technology platform to create a new generation of homogenous antibody drug conjugates with site-specific toxin conjugation and consistent drug-antibody ratios. With the close of the deal, Sorrento has issued an aggregate of 1,331,978 shares of its common stock to the Concortis shareholders. Based on the closing share price on December 18, 2013, the transaction is valued at $11.3 million.
› Verified 3 days ago
Entity Name | Greater Knoxville Ear Nose And Throat Associates Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1578647806 PECOS PAC ID: 0244126126 Enrollment ID: O20040226000686 |
News Archive
Imaging Dynamics Company Ltd. a global leader in the high growth digital radiography (DR) equipment market, today reported financial results for the first quarter ended March 31, 2010.
CLEAR, the powerful public and proprietary records service and investigative suite from Thomson Reuters, is well-regarded among law enforcement and government investigative professionals for helping nab criminals and recover missing children. Today, the business is introducing a new version of the service to aid in the recovery of the $60 billion that the National Health Care Anti-Fraud Association estimates is lost each year to fraud.
The U.S. Food and Drug Administration announced today that Baxter Healthcare Corporation has temporarily stopped manufacturing multiple-dose vials of the injectable blood-thinning drug heparin due to reports of serious allergic reactions and hypotension (low blood pressure) in patients who receive high "bolus" doses of the drug.
Data presented today at The International Liver Congress 2015 demonstrates that remogliflozin etabonate, an investigational drug in type 2 diabetes, is a potential treatment option for the management of patients with non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD).
Sorrento Therapeutics, Inc. announced today that it has completed its acquisition of Concortis Biosystems, Corp., providing Sorrento with a comprehensive technology platform to create a new generation of homogenous antibody drug conjugates with site-specific toxin conjugation and consistent drug-antibody ratios. With the close of the deal, Sorrento has issued an aggregate of 1,331,978 shares of its common stock to the Concortis shareholders. Based on the closing share price on December 18, 2013, the transaction is valued at $11.3 million.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr William D Horton Ii, MD 7557a Dannaher Drive, Suite 210, Powell, TN 37849-3558 Ph: (865) 521-8050 | Dr William D Horton Ii, MD 7557a Dannaher Drive, Suite 210, Powell, TN 37849-3558 Ph: (865) 521-8050 |
News Archive
Imaging Dynamics Company Ltd. a global leader in the high growth digital radiography (DR) equipment market, today reported financial results for the first quarter ended March 31, 2010.
CLEAR, the powerful public and proprietary records service and investigative suite from Thomson Reuters, is well-regarded among law enforcement and government investigative professionals for helping nab criminals and recover missing children. Today, the business is introducing a new version of the service to aid in the recovery of the $60 billion that the National Health Care Anti-Fraud Association estimates is lost each year to fraud.
The U.S. Food and Drug Administration announced today that Baxter Healthcare Corporation has temporarily stopped manufacturing multiple-dose vials of the injectable blood-thinning drug heparin due to reports of serious allergic reactions and hypotension (low blood pressure) in patients who receive high "bolus" doses of the drug.
Data presented today at The International Liver Congress 2015 demonstrates that remogliflozin etabonate, an investigational drug in type 2 diabetes, is a potential treatment option for the management of patients with non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD).
Sorrento Therapeutics, Inc. announced today that it has completed its acquisition of Concortis Biosystems, Corp., providing Sorrento with a comprehensive technology platform to create a new generation of homogenous antibody drug conjugates with site-specific toxin conjugation and consistent drug-antibody ratios. With the close of the deal, Sorrento has issued an aggregate of 1,331,978 shares of its common stock to the Concortis shareholders. Based on the closing share price on December 18, 2013, the transaction is valued at $11.3 million.
› Verified 3 days ago
Stewart H Bernard, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 7557 Dannaher Dr Ste 210a, Powell, TN 37849 Phone: 865-521-8050 Fax: 865-947-7907 | |
Dr. Ronald K Sandberg, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 7557a Dannaher Dr, Suite 210, Powell, TN 37849 Phone: 865-521-8050 Fax: 865-544-5816 | |
Dr. Richard J Depersio, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 7557a Dannaher Dr, Suite 210, Powell, TN 37849 Phone: 865-521-8050 Fax: 865-544-5216 | |
Dr. Robert A Crawley, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 7557a Dannaher Dr, Suite 210, Powell, TN 37849 Phone: 865-521-8050 Fax: 865-544-5816 | |
Dr. Christopher J Rathfoot, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 7557a Dannaher Dr, Suite 210, Powell, TN 37849 Phone: 865-521-8050 Fax: 865-544-5816 | |
Dr. Allan M Rosenbaum, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 7557 A Dannaher Drive, Suite 210, Powell, TN 37849 Phone: 865-521-8050 Fax: 865-544-5816 | |
Sarah Kortebein, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 7680 Dannaher Drive, Powell, TN 37849 Phone: 865-521-8050 Fax: 865-544-5816 |